Korean Cancer Study Group
🇰🇷South Korea
Clinical Trials
10
Active:1
Completed:1
Trial Phases
4 Phases
Phase 1:2
Phase 2:5
Phase 3:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (50.0%)Not Applicable
2 (20.0%)Phase 1
2 (20.0%)Phase 3
1 (10.0%)Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer
- First Posted Date
- 2021-10-15
- Last Posted Date
- 2021-10-15
- Lead Sponsor
- Korean Cancer Study Group
- Target Recruit Count
- 40
- Registration Number
- NCT05079503
A Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- Korean Cancer Study Group
- Target Recruit Count
- 48
- Registration Number
- NCT04761744
- Locations
- 🇰🇷
Korean Cancer Study Group, Seoul, Chongro-ku, Korea, Republic of
🇰🇷Korea University Anam Hospital, Seoul, Seongbuk-gu, Inchon-ro, Korea, Republic of
Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients
Phase 1
Active, not recruiting
- Conditions
- PIK3CA Gene MutationMetastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2021-02-15
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Korean Cancer Study Group
- Target Recruit Count
- 65
- Registration Number
- NCT04753203
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)
Phase 1
Withdrawn
- Conditions
- Colorectal Cancer Metastatic
- Interventions
- First Posted Date
- 2021-02-12
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Korean Cancer Study Group
- Registration Number
- NCT04751955
Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer
Phase 2
- Conditions
- Metastatic Breast CancerHER2-positive Breast Cancer
- Interventions
- First Posted Date
- 2018-10-09
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Korean Cancer Study Group
- Target Recruit Count
- 15
- Registration Number
- NCT03698383
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
- Prev
- 1
- 2
- Next
News
No news found